E chocardiography is crucial for the evaluation of heart diseases, because treatment decisions frequently rely on accurate determination of the sizes of cardiovascular structures.
The Pediatric Heart Network Echo Z Scores race, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] though most focus on the effects of body size using cardiovascular allometry (relationship between cardiovascular growth and total body growth) and Z scores. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] With increasing use of Z scores in echocardiography, the limitations have become apparent. [22] [23] [24] Cantinotti et al 22 revealed wide Z score variation for the same measurement when evaluating published normal databases, many with small sample sizes, few neonates, and heterogeneous methodologies using variable body size parameters and regression equations. For example, a mitral diameter of 11 mm in a boy with a body surface area (BSA) of 0.3 m 2 can correspond to a Z score of −3.5 to +4.8. Many studies also failed to address the problem of nonconstant variance (heteroscedasticity). [22] [23] [24] Colan et al 25 highlighted the reproducibility of echocardiographic measurements, potentially creating additional challenges to establishing normal databases. Most studies have reported interobserver variability as percent differences of 5% to 10% for semilunar and >10% for atrioventricular valvar measurements. [3] [4] [5] [6] [7] 26, 27 Currently, normal echocardiographic reference values adjusted for body size, age, sex, race, and ethnicity do not exist. The Pediatric Heart Network sought to determine Z scores for common measurements in a large group of racially diverse healthy children by evaluating the relationship between measurements and BSA as well as the effects of age, sex, race, and ethnicity on this relationship.
Methods
The detailed methods used for measurement performance and data analysis will be made available on request from the Pediatric Heart Network to other researchers. In addition, the regression equations and a Z score calculator will be available on the Pediatric Heart Network website (www.pediatricheartnetwork.com).
Study Design
Demographic and clinical data and echocardiographic images were collected at 19 North American centers. Because all submissions were deidentified, most children were retrospectively enrolled under a waiver of consent after Institutional Review Board or Research Ethics Board approval. Race/ethnicity information was not routinely obtained at 1 center and was collected prospectively for eligible subjects after local regulatory approval. Some centers were able to perform research echocardiograms without charge and prospectively enrolled healthy children after Institutional Review Board approval.
Study Population
Healthy children ≤18 years of age with a normal, high-quality echocardiogram and documentation of height, weight, sex, race, and ethnicity were eligible. Exclusion criteria (Table I in the Data Supplement) included structural heart disease, abnormal electrocardiographic findings, systemic disorder with cardiovascular manifestations, prematurity because of a high prevalence of hemodynamically significant cardiovascular and respiratory pathology, obesity because of reported associated cardiovascular pathology, 28, 29 and a family history of nonischemic cardiomyopathy or congenital left-sided heart disease. 30, 31 An adjudication committee evaluated anatomic variants (Table 1) , and normal or hemodynamically insignificant findings were included.
Self-reported race/ethnicity information was divided into 3 categories: whites, blacks, and others (Hispanics, Asians, Pacific Islanders, Native Americans, and Multiracial). Age was divided into 6 categories (<1 month, 1 month-3 years, 3-6 years, 6-12 years, 12-16 years, and 16-18 years) to assure adequate enrollment across the full pediatric age range (particularly during periods of increased growth velocity), but age was treated as a continuous variable during the analyses. Thirty-six study groups were created from the 3 race, 6 age, and 2 sex categories. Sample size calculations were performed to reasonably estimate the population mean and SD for each measurement. 32 Specifying a margin of error for the mean of 22% of the SD required 80 echocardiograms per group. Because ≥80% of submitted studies were expected to contain the necessary images for each measurement, the target was 100 subjects per group.
Echocardiographic Studies
All echocardiograms were in Digital Imaging and Communications in Medicine format with ≥2-beat clips. Images were deidentified using the Match Plus Program (Booz Allen Hamilton, McLean, VA) and submitted to the Core Laboratory where measurements were performed using published pediatric quantification standards (Table 2) . 1 Pulmonary annular diameters were performed in short-and long-axis parasternal views; a single predesignated view was used for all other measurements. Measurements were performed off-line (TomTec, Unterschleissheim, Germany) by 1 of 2 Core Laboratory sonographers and reviewed by the Director. The echocardiogram was included if the Core Laboratory could perform all required measurements and measurements in at least 1 of the 3 optional categories in Table 2 (structures not routinely measured in normal studies).
Intraobserver variability was evaluated with blinded repeat measurements of aortic annular, root, sinotubular junction, and ascending aortic diameters and left ventricular (LV) end-diastolic area in 120 subjects. Depending on the true proportion of matched measurements (assuming a 90% to 50% range), 120 subjects provided a 90% confidence interval for the true proportion with a reasonable margin of error (0.045-0.075). Measurement variability was tested using intraclass correlation coefficients and Pearson correlations.
Statistical Analysis
Because most clinicians use the BSA formulas by Haycock 33 and by Gehan and George, 34 the calculated BSAs using both formulas were compared by Pearson correlation. Because the goal was to calculate Z scores based on BSA while accounting for the effects of age, sex, race, and ethnicity, a P value of 0.05 was used to determine significant effects, and a P value of 0.01 was used to determine significant interactions among the effects. Published reproducibility thresholds suggest that measurement variability may be responsible for up to 5% of measurement differences.
3-7,25-27 Therefore, clinical % Av indicates percent of studies with available images; % Diff, percent differences of mean indexed values for models with and without significant effects and interactions; A, age; A×R, interaction between age and race; A×S, interaction between age and sex; A×S×R, interaction among age, sex, and race; AAO, ascending aortic diameter; ANN, aortic annular diameter; ARCH DIST , distal transverse arch diameter; ARCH PROX , proximal transverse arch diameter; effects, statistically significant effects and interactions with multivariable regression; BSA, body surface area; ISTH, aortic isthmus diameter; LAD, proximal left anterior descending coronary artery diameter; LMCA, left main coronary artery diameter; LPA, left pulmonary artery diameter; LV, left ventricular; LVEDA, LV short-axis end-diastolic endocardial area; LVEDA EPI , LV short-axis end-diastolic epicardial area; LVEDD, LV short-axis end-diastolic endocardial diameter; LVEDL, LV long-axis end-diastolic endocardial length; LVEDL EPI , LV long-axis end-diastolic epicardial length; LVEDV, LV short-axis end-diastolic endocardial volume; LVEDV EPI , LV short-axis end-diastolic epicardial volume; LVM, LV mass; LVMTV, LV mass:volume ratio; LVPWT, LV short-axis end-diastolic posterior wall thickness; LVSI, LV sphericity index; LVST, LV short-axis end-diastolic septal thickness; LVTTD, LV thickness:dimension ratio; mean, mean indexed parameter value; MPA, main pulmonary artery diameter; MVA, mitral area; MV AP , mitral anteroposterior diameter; MV LAT , mitral lateral diameter; PV LAX , pulmonary annular long-axis diameter; PV SAX , pulmonary annular short-axis diameter; R, race; RCA, proximal right coronary artery diameter; req, required parameter; ROOT, aortic root diameter; RPA, right pulmonary artery diameter; S, sex; S×R, interaction between sex and race; slope ∆, slope change at ≈6 y age in indexed parameter vs age relationships; STJ, sinotubular junction; TVA, tricuspid area; TV AP , tricuspid anteroposterior diameter; TV LAT , tricuspid lateral diameter; and α, exponent for BSA transformation (BSA α ). *For optional measurements, each study must contain all 3 measurements from only one of the following groups: (1) ARCHPROX, ARCHDIST, ISTH; (2) LMCA, LAD, RCA; and (3) MPA, RPA, LPA.
†For pulmonary annular diameters, a parasternal short-and/or long-axis measurement was required. ‡These parameters do not have a significant relationship with BSA, so BSA is not used in Z score derivation.
significance was defined as a difference of at least 5% between actual and predicted measurement values using models with and without the significant effects. Based on physiologically driven methodologies for indexing cardiovascular measurements, 9,10 models with nonlogarithmic BSA transformations (BSA α ) and no measurement transformations were used, beginning with results from a prior study. 10 The exponent α for each measurement was tested for the following criteria:
• The indexed parameter (X/BSA α ) had a normal distribution.
• There was no residual relationship between X/BSA α and BSA (the slope of the relationship was not significantly different from zero). If the slope was statistically significantly different from zero, clinical significance was tested by creating a zero-slope line at the mean X/BSA α and comparing raw values from the nonzero-and zero-slope lines at the first and third BSA quartiles; if the percent difference was <5% at both quartiles, the persistent relationship between X/BSA α and BSA was considered clinically insignificant. If the percent difference was ≥5% or X/BSA α was not normally distributed, other exponents were tested.
Once BSA α was chosen, multivariable regression assessed the linear effects of age, sex, and race and their interactions. Race was coded as a 3-level categorical variable in all regression models involving the significant main effects and interactions, with the race category of white chosen as the reference category. Ethnicity represented only a fraction of 1 race category and was not included initially. Backwards elimination model selection, excluding BSA as a predictor, determined the final model. Higher order interactions were considered first and removed if insignificant. Lower order interactions and main effects were kept even if insignificant when the effect was part of a significant higher order interaction.
If an interaction was statistically significant, predicted values transformed to raw measurements from the model with the interaction were compared with those from the model without the interaction. A 1-sided t test was used on the absolute proportion difference between the 2 models with a null hypothesis of a mean proportion ≥0.05 against the alternative hypothesis of a mean proportion <0.05. An absolute mean percent difference between predicted values <5% was considered clinically insignificant. If an effect was statistically significant, a similar method determined clinical significance. Predicted values from a model containing statistically significant effects were compared with those from a model without effects, and a mean percent difference <5% by 1-sided t test was considered clinically insignificant. A similar secondary analysis explored the effect of ethnicity, comparing raw values from a model that included ethnicity as a predictor and one without predictors, and a mean percent difference <5% was considered clinically insignificant.
Age as a continuous variable was tested for nonlinear effects by plotting X/BSA α against age, first with nonparametric locally weighted scatterplot smoothing curve fitting, then with piecewise linear regression. Discrete discrepancies in slope were tested for clinical significance by comparing predicted values from a model that included the separate slopes and one without changes in slope; again, a mean percent difference <5% was considered clinically insignificant. Finally, the mean and SD (Z scores) of the indexed parameters were determined while accounting for any clinically significant effects and interactions. The nonindexed parameters were plotted against BSA along with lines depicting the mean and 2 SDs above and below the mean.
Results
Of the 3566 subjects, 3215 (90%) had adequate images. Race data revealed 35% whites, 31% blacks, and 34% others. Ethnicity data revealed 25% Hispanic, 70% non-Hispanic, and 5% unknown. All study groups reached ≥complete enrollment (≥80 subjects with measurable images) except black girls age <1 month, 3 to 6 years, and 16 to 18 years, black boys age <1 month, and other girls age 16 to 18 years (Table   II in the Data Supplement) . For all the required parameters, eligible images were available in 100% (Table 2) . For the pulmonary annulus, eligible images were available in 71% for short-and 90% for long-axis diameters. For optional measurements, eligible images were available in 78% to 97%. Intraobserver variability at the Core Laboratory was low with an intraclass correlation coefficient of 1.00 and Pearson correlations >0.99 for all 5 parameters.
BSA Transformation for Indexed Parameters
Comparison of BSA calculations using the Haycock and Gehan/George formulas revealed a Pearson correlation >0.99. The Haycock formula was used for all analyses since prior reports have shown it to be the best predictor of cardiovascular sizes.
10,17 LV mass:volume ratio, thickness:dimension ratio, and sphericity index did not have a clinically significant relationship with BSA, so these parameters were not indexed to BSA. For the other parameters, the selected BSA transformation resulted in a normal distribution for all indexed parameters (X/BSA α ), but most relationships between X/ BSA α and BSA were statistically significant with a nonzero slope ( Table 2 ). However, comparison of the actual parameter values against the predicted values for a zero-slope model at the first and third BSA quartiles revealed an absolute percent difference <5% for all parameters (Table III in the Data  Supplement) . For example, the percent differences for the linear measurements in centimeters involved raw value differences that were all <1 mm, suggesting that the differences could be attributable to measurement variability. Therefore, all residual relationships between X/BSA α and BSA were deemed clinically insignificant.
Model Selection
Multivariable regression for all parameters revealed statistically significant effects by age, sex, and race as well as significant interactions (Table 2) . However, comparison of these results against models without effects or interactions revealed that none involved clinically significant differences. When considering the amount of variance explained by the models (R 2 ), the maximum increase in R 2 when including age, sex, and race in addition to BSA was 0.018, suggesting that the added contribution of age, sex, and race to predicting these parameters was minimal. For the 3 parameters not indexed to BSA, the maximum R 2 of models including age, sex, and race was 0.089, again suggesting little contribution of these factors. Two hypothetical subjects were created to highlight this point: an 18-month-old black boy at the first BSA quartile (0.43 m 2 ) and a 14-year-old white boy at the third BSA quartile (1.51 m 2 ). The predicted mean aortic root diameters for each subject in the model with the effects were 1.33 and 2.62 cm, compared with 1.35 and 2.53 cm in the model without the effects. These differences were <1 mm highlighting the absence of clinically significant differences between the models. A similar exercise for LV end-diastolic diameters revealed predicted mean values of 2.65 and 4.79 cm from the model with the effects and 2.65 and 4.68 cm from the model without the effects, again emphasizing the absence of clinically significant differences. The Pediatric Heart Network Echo Z Scores Testing for nonlinear effects of age revealed an apparent transition in slopes at ≈6 years of age in 16/34 parameters (Table 2) . However, comparing predicted values revealed an absolute percent difference <5% for all parameters, indicating that age as a continuous variable did not have a clinically significant effect. Assessment of the relationship between ethnicity and indexed parameters also resulted in clinically insignificant effects.
After the effects of age, sex, race, and ethnicity were deemed clinically insignificant, the final models were established (Table 2) , underscoring the absence of heteroscedasticity in the relationship between the indexed parameter and BSA. The nonindexed parameters were then plotted against BSA with lines representing the mean values and 2 SDs above and below the mean ( Figure I in the Data Supplement), revealing the nonconstant variance (heteroscedasticity) of this relationship. Based on the models, the Z score of a measurement for a specific BSA can be calculated from Table 2 by using the specified α, mean, and SD for that parameter: The Z scores for LV mass:volume ratio, thickness:dimension ratio, and sphericity index can be calculated using the raw values without adjusting for BSA.
Discussion
This is the first study with adequate sampling to evaluate the effects of age, sex, race, and ethnicity on cardiovascular sizes in a large group of healthy North American children. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] 20, 21 We derived reference values for common measurements across the full range of ages and body sizes encountered in healthy nonobese children, and we plan to make them publicly available on the Pediatric Heart Network website and through other resources. Our allometric scaling methodology with physiologically driven models used the fluid dynamics principles of minimal work and vascular tree development. This previously validated approach 10 involved nonlogarithmic BSA transformations and no measurement transformations, unlike other studies using statistically driven methodologies that test multiple models for the best fit. 8, [12] [13] [14] 16, 17 Because of the large sample size, the confounding factors of age, sex, and race and their interactions had statistically significant effects on the relationship between cardiovascular and body size. However, the raw differences associated with these effects were less than the reproducibility thresholds of most echocardiographic measurements and more likely secondary to measurement variability than true clinically significant effects. Although age had no clinically significant effect on the derived Z scores, the slope change at age 6 years for many of the indexed parameters is difficult to explain. The consistency of the age of this slope change suggests that other factors not evaluated in this analysis may be responsible.
The absence of clinically significant effects of age, sex, race, and ethnicity on the Z scores is our most important finding, unlike prior studies showing sex differences in valvar measurements 12 and sex and race differences in LV measurements. 20, 21 Models with specified BSA transformations, normally distributed indexed parameters, and no clinically significant residual relationship between indexed parameters and BSA allowed us to characterize the relationship of each nonindexed parameter with BSA despite the nonconstant variance of these relationships (heteroscedasticity; Figure I in the Data Supplement). The body size parameter used for normalization remains controversial. Some studies used weight to predict cardiovascular sizes, particularly in neonates. 5, 11 Some incorrectly assumed a linear relationship between the sizes of all cardiovascular structures and BSA, 18, 19 whereas others used models with exponential 9, 10 or logarithmic 8 transformations of BSA or logarithmic transformation of both BSA and the measurements, [12] [13] [14] 16 ,17 a statistically sound approach without physiological justification. Many studies used the DuBois/DuBois BSA formula 35 even though only 9 individuals and no children were used in its derivation. 11, 12, 14 The Haycock formula 33 was the best predictor of cardiovascular sizes in recent studies, 10,17 correlated well with the Gehan/George formula, and was therefore selected for use in this analysis. Height has been used for allometric scaling, particularly with LV mass reference values for obese individuals. 15, 36 Cardiac size is driven by cardiac output and fat has a lower metabolic rate and less blood flow, so height correlates better with fat-free body mass. [37] [38] [39] Because obese individuals were excluded and BSA is the best predictor of LV mass in normal children, 15 ,40 height was not used for allometric scaling of LV mass in this study.
This study was limited by its retrospective design. Healthy children were identified by searching hospital databases for patients with a normal echocardiogram, a self-referential definition that may incur a patient selection bias. The study protocol required rigorous review of medical records and strict elimination of subjects with abnormal findings on any diagnostic study, but no records were reviewed after the study period to exclude subsequent abnormal findings. Indications for the echocardiograms were not collected and their effect on the study findings could not be evaluated.
The National Institutes of Health definitions for race and ethnicity frequently differed from local definitions, leading to a widely diverse other race category. This study focused primarily on whites and blacks, so our findings may be less applicable to children of other races. Other potential confounders, such as nutrition, exercise, and altitude, may play a role in cardiovascular growth within and outside North America, but our retrospective enrollment limited to North American centers precluded their evaluation.
Prospective measurements by Core Laboratory observers obviate the variability limitations of a retrospective multicenter study. However, having only 2 rather than multiple observers at multiple sites may result in smaller SDs and may not reflect real world practice. Last, other modalities such as M-mode, Doppler, speckle tracking, and 3-dimensional echocardiography were not evaluated. Similarly, end-systolic and functional measurements (LV shortening and ejection fraction) were not included because these parameters are likely affected by factors (heart rate, basal metabolic rate, exercise, altitude, and hematocrit) other than body size. The Pediatric Heart Network Echo Z Scores
Conclusions
This study establishes a large normative database derived from healthy, racially diverse North American children for the most common 2-dimensional echocardiographic measurements. The Pediatric Heart Network will publish the regression equations in its public website and through other resources. BSA raised to a specified power is a good parameter for cardiovascular allometric scaling, and none of the Z score models for the measurements in this study were affected by age, sex, race, or ethnicity.
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